Cargando...
Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications
Osteoporosis is a disease characterized by a low bone volume and deterioration of the bone quality, which increases the risk of low-energy fractures. Bisphosphonate (BP) treatment increases the bone mass and reduces the risk of fractures in patients with osteoporosis by suppressing bone resorption....
Guardado en:
| Publicado en: | Ther Adv Chronic Dis |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480549/ https://ncbi.nlm.nih.gov/pubmed/26137208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315584114 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|